Viewing data from:

BENZTROPINE MESYLATE

ANDA

BENZTROPINE MESYLATE | A090294 | INVAGEN PHARMACEUTICALS INC

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 3 NDCs

Highest NADAC/Unit

$0.0900

per ea

Lowest NADAC/Unit

$0.0638

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69097083207BENZTROPINE MES 2 MG TABLET	$0.0900	EA	Generic	—	2026-10-21
69097082707BENZTROPINE MES 1 MG TABLET	$0.0739	EA	Generic	—	2026-10-21
69097082607BENZTROPINE MES 0.5 MG TAB	$0.0638	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain8 active DMFs1 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

FINE CHEMICALS CORP PTY LTDBENZTROPINE MESYLATE

DMF 69141987

DR REDDYS LABORATORIES LTDBENZTROPINE MESYLATE USP

DMF 70331987

ARCH PHARMALABS LTDBENZTROPINE MESYLATE USP

DMF 237192010

CURIA WISCONSIN INCBENZTROPINE MESYLATE

DMF 288402015

NAVINTA LLCBENZTROPINE MESYLATE USP

DMF 321362018

HARMAN FINOCHEM LTDBENZTROPINE MESYLATE USP

DMF 331262018

ESCIENTIA ADVANCED SCIENCES PRIVATE LTDBENZTROPINE MESYLATE USP

DMF 334802019

KALINTIS HEALTHCARE PVT LTDBENZTROPINE MESYLATE USP

DMF 349642020

ORION CORP LTDInactiveBENZTROPINE MESYLATE

DMF 61891986

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 0.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 29, 2010

No patent or exclusivity listings for this strength.

#002 — 1MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 29, 2010

#003 — 2MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 29, 2010